Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Eclampsia y síndrome HELLP en los Andes del Perú: complicaciones perinatales

Eclampsia and HELLP syndrome in the Peruvian Andes: perinatal complications.

Ginecol Obstet Mex. 2018 noviembre;86(11):718-723.

https://doi.org/10.24245/gom.v86i11.2266

Jorge Arturo Collantes-Cubas,1 Paulino Vigil-De Gracia,2 Jorge Alberto Benza-Bedoya,1 José Avelino Mendo-Aguilar,1 Segundo Alberto Pérez-Ventura,1 Silvia Vigo-Valera1

1 Hospital Regional Docente de Cajamarca, Perú.
2 Complejo Hospitalario Arnulfo Arias Madrid, Caja de Seguro Social, Panamá, investigador distinguido del Sistema Nacional de Investigación de Panamá.


Corrrespondencia:

Paulino Vigil De Gracia
pvigild@hotmail.com

Debe citarse como:

Collantes-Cubas JA, Vigil-De Gracia P, Benza-Bedoya JA, Mendo-Aguilar JA, Pérez-Ventura SA, Vigo-Valera S. Eclampsia y síndrome HELLP en los Andes del Perú: complicaciones perinatales. Ginecol Obstet Mex. 2018 noviembre;86(11):718-723. doi: https://doi.org/10.24245/gom.v86i11.2266

Resumen

OBJETIVO: Comparar las complicaciones perinatales en pacientes con eclampsia, síndrome HELLP y su asociación.

MATERIALES Y MÉTODOS: Estudio transversal y comparativo efectuado en mujeres con eclampsia, síndrome HELLP, o ambos, y sus neonatos atendidas en el Hospital Regional Docente de Cajamarca, Perú, entre el 1 de enero y el 31 de diciembre de 2015. La información se procesó con el programa Epi Info versión 7. Se usó la ANOVA y χ2 no paramétrica con Kruskal-Wallis para comparar grupos, y se consideró significativo un valor de p < 0.05.

RESULTADOS: Se registraron 3411 nacimientos; 71 pacientes tuvieron eclampsia o síndrome HELLP. Las complicaciones perinatales de prematurez, menor peso y talla al nacer y Apgar más bajo fueron significativamente mayores en mujeres con síndrome HELLP que con eclampsia. En cuanto a prematurez hubo 30 (66.6%) casos de madres con síndrome HELLP, 14 (70%) con eclampsia asociada con síndrome HELLP y ninguno con eclampsia (p = 0.01). El peso promedio al nacimiento fue 2133.5 ± 66.7 g en síndrome HELLP y 3083.1 ± 67.8 g en eclampsia (p = 0.001). Hubo Apgar más bajo al minuto y a los cinco minutos en la combinación eclampsia y síndrome HELLP que en solo eclampsia (p = 0.002). No hubo diferencias significativas en la mortalidad, restricción del crecimiento fetal, asfixia neonatal, taquipnea transitoria, enfermedad de membranas hialinas, enterocolitis necrotizante, policitemia, ictericia patológica o sepsis. La tasa de cesáreas en síndrome HELLP fue 41 (91.1%) y en eclampsia 4 (66.6%) (p = 0.03).

CONCLUSIONES: Las complicaciones perinatales son mayores pacientes con síndrome HELLP que con eclampsia.

PALABRAS CLAVE: Perinatal; eclampsia; síndrome HELLP; asfixia; taquipnea; membrana hialina; enterocolitis necrotizante; policitemia; sepsis.

Abstract

OBJECTIVES: To compare perinatal complications in patients with eclampsia, HELLP syndrome and association.

MATERIALS AND METHODS: a cross-sectional, comparative study conducted in women with eclampsia and / or HELLP syndrome and their perinates in Hospital Regional Docente de Cajamarca , Peru. Data obtained from 01/01/2015 to 12/31/15. Information processing was carried out with the Epi Info program version 7. The ANOVA and non-parametric χ2 with Kruskal-Wallis were used to compare groups, and a value of P <0.05 was considered significant.

RESULTS: 71 women had eclampsia and / or HELLP syndrome of 3411 births. Perinatal complications such as prematurity, lower weight and height at birth and lower Apgar were significantly higher in HELLP syndrome than in eclampsia. Regarding prematurity, there were 30 (66.6%) in HELLP syndrome, 14 (70%) in eclampsia associated with HELLP syndrome and none in eclampsia (p = 0.01). Birth weight was 2133.5 ± 66.7 g in HELLP syndrome and 3083.1 ± 67.8 g in eclampsia (p = 0.001). Apgar was lower at minute and at 5 minutes in the combination eclampsia and HELLP syndrome than in eclampsia alone (p = 0.002). There were no significant differences in mortality, IUGR, neonatal asphyxia, transient tachypnea, hyaline membrane disease, necrotizing enterocolitis, polycythemia, pathological jaundice or sepsis. The rate of cesareans in HELLP syndrome was 41 (91.1%) and in eclampsia 4 (66.6%) (p = 0.03).

CONCLUSIONS: Perinatal complications are greater in HELLP syndrome than in eclampsia.

KEYWORDS: Perinatal; Eclampsia; HELLP syndrome; Asphyxia; Tachypnea; Hyaline membrane; Necrotizing enterocolitis; Polycythemia; Sepsis.

    1. Sibai B. Hypertensive disorders in pregnancy. Clinical Obstet Gynecol 2017; 60(1):133-8. doi: 10.1097/01.grf.0000512349.03677.66
    2. The American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Practice Guideline, 2013. https://acog.org/media.
    3. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365:785-99. doi: 10.1016/S0140-6736(05)17987-2
    4. Sibai BM. Diagnosis, Prevention, and Management of Eclampsia. Obstet Gynecol 2005; 105:402-10. doi: 10.1097/01.AOG.0000152351.13671.99
    5. Sibai BM. Diagnosis, Controversies, and Management of the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count. Obstet Gynecol 2004; 103:981-91. doi: 10.1097/01.AOG.0000126245.35811.2a
    6. Vigil-De Gracia P, et al. Incidence of eclampsia with HELLP syndrome and associated mortality in Latin America. Int J Gynecol Obstet 2015; 129 (3): 219-22. https://doi.org/10.1016/j.ijgo.2014.11.024
    7. Rojas P, y col. Complicaciones neonatales del síndrome HELLP. An Pediatr (Barc) 2009; 70(2):159-63. doi: 10.1016/j.anpedi.2008.08.023
    8. González-Álvarez CE, y col. Hijo de madre con síndrome de HELLP: características y papel de la prematuridad, bajo peso y leucopenia en su evolución. Bol Med Hosp Infant Mex 2015; 72(5):318-324. http://dx.doi.org/10.1016/j.bmhimx.2015.09.006.
    9. Figueras F, et al. An integrated approach to fetal growth Restriction. Best Practice & Research Clinical Obstetrics and Gynaecology 2017; 38:48-58. https://doi.org/10.1016/j.bpobgyn.2016.10.006
    10. Raymond D, et al. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv 2011;66 (8):497-506. doi: 10.1097/OGX.0b013e3182331028
    11. Lisonkova S, et al. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 2013; 209:544.e1-12. https://doi.org/10.1016/j.ajog.2013.08.019
    12. Valensise H, et al. Early and Late Preeclampsia. Two Different Maternal Hemodynamic States in the Latent Phase of the Disease. Hypertension 2008; 52:873-80. doi: 10.1161/HYPERTENSIONAHA.108.117358.
    13. Rolnik DL, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017; 377: 613-22. doi: 10.1097/01.aoa.0000529983.77883.af
    14. Poon LC, et al. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol 2017; 217:585.e1-5. https://doi.org/10.1016/j.ajog.2017.08.110
    15. Savchev S, et al. Estimated weight centile as a predictor of perinatal outcome in small-for-gestational-age pregnancies with normal fetal and maternal Doppler indices. Ultrasound Obstet Gynecol 2012; 39: 299-303. DOI: 10.1002/uog.10150
    16. Romero R, et al. Fetal size standards to diagnose a small- or a large-for-gestational-age fetus. Am J Obstet Gynecol 2018;218(2): S605-607. doi: 10.1016/j.ajog.2017.12.217
    17. Deter RL, et al. Individualized growth assessment: conceptual framework and practical implementation for the evaluation of fetal growth and neonatal growth outcome. Am J Obstet Gynecol 2018;218(2): S656-78. doi: 10.1016/j.ajog.2017.12.210
    18. Pauli JM, et al. Pitfalls with the New American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy. Clin Obstet Gynecol 2017; 60(1):141-152. doi: 10.1097/GRF.0000000000000247
    19. von Dadelszen P, et al. Prediction of adverse maternal outcomes in preeclampsia: development and validation of the fullPIERS model. Lancet 2011; 377:219-27. https://doi.org/10.1016/S0140-6736(10)61351-7
    20. Payne B, et al. Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of Risk) cohort, collected on admission. BJOG 2013; 120:113-18. https://doi.org/10.1111/j.1471-0528.2012.03496.x
    21. Payne B, et al. A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: The miniPIERS (Pre-eclampsia Integrated Estimate of Risk) Multi-country Prospective Cohort Study. PLoS Med 2014;11(1): e1001589. https://doi.org/10.1371/journal.pmed.1001589
    22. Payne BA, et al. Assessing the Incremental Value of Blood Oxygen Saturation (SpO2) in the mini PIERS (Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model. J Obstet Gynaecol Can 2015; 37(1):16-24. https://doi.org/10.1016/S1701-2163(15)30358-3
    23. Ukah U, et al. Development and internal validation of a multivariable model to predict perinatal death in pregnancy hypertension. Pregnan Hyperten 2015; 5:315-21. https://doi.org/10.1016/j.preghy.2015.08.006
    24. Ukah UV, et al. Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review. Pregnan Hyperten 2018; 11:115-23. https://doi.org/10.1016/j.preghy.2017.11.006
    25. Burwick RM, et al. Eculizumab for the treatment of preeclampsia/HELLP syndrome. Placenta 2013;34(2):201-3. https://doi.org/10.1016/j.placenta.2012.11.014

Comentarios